ERF Transcription Factor NaERFIDOG Regulates JA‐Induced Defence and Growth Inhibition in Nicotiana attenuata Upon Alternaria alternata Infection Authors: Luyan Zhao, Na Song, Lei Wang, Jinsong Wu Published: 2026 ABSTRACT ABSTRACTJasmonate (JA) regulates defence responses in plants. However, JA‐induced defence often results in growth inhibition. This process is largely mediated by MYC2, the master regulator of JA signalling. Nevertheless, the underlying molecular mechanisms have not yet been fully uncovered. Here, we discovered that the ERF transcription factor NaERFIDOG plays a key role in the JA‐induced defence over growth in Nicotiana attenuata upon infection by the notorious fungal pathogen Alternaria alternata . NaERF IDOG expression was directly controlled by JA through NaMYC2a/b. Plants silenced or knocked out for either NaERF IDOG or both NaMYC2a and NaMYC2b exhibited similar phenotypes: they were both more vulnerable to A. alternata but grew larger. However, stable overexpression of NaERF IDOG increased resistance to the fungus and reduced growth in both wild‐type (WT) plants and those co‐silenced with NaMYC2a/b to a similar extent. Further analysis indicated that NaERFIDOG binds directly to the promoters of the biosynthetic genes for scopoletin, JA and GA, including NaF6'H1, NaAOS and NaKAO1‐like, thereby activating scopoletin and JA biosynthesis while suppressing GA biosynthesis. Finally, our results revealed that both increasing scopoletin levels and reducing GA biosynthesis were involved in JA‐induced disease resistance and growth inhibition. Thus, our study revealed how JA prioritizes defence against A. alternata over growth by a novel regulatory network, JA‐MYC2‐ERFIDOG‐Scopoletin/JA/GA. These findings provide new insights into the molecular mechanisms underlying the trade‐off between defence and growth in plants and highlight the key role of NaERFIDOG in the biosynthesis of scopoletin, JA and GA. Introduction Jasmonate (JA) is an important phytohormone that regulates defence responses to diseases and pests in plants (Wasternack and Hause 2013; Wasternack and Strnad 2016). However, activating JA signalling also inhibits plant growth (Yang et al. 2012; Liu et al. 2021; He et al. 2022). Currently, the mechanism by which JA inhibits plant growth is not yet fully understood. Major et al. (2017) found that the jaz1/3/4/9/10 mutant plants exhibited significant growth inhibition due to JA activation in Arabidopsis. In contrast, myc2/3/4 mutant plants had enhanced growth due to JA signalling blockade. The growth phenotype of jaz1/3/4/9/10 was restored when it was crossed with myc2/3/4. This result indicates that JA‐induced inhibition of Arabidopsis growth is dependent on MYC2/3/4. Recently, it was found that MYC2 binds to the promoter of the GA degradation enzyme gene (GA2ox) to activate its expression when rice is attacked by brown planthoppers (Jin et al. 2023). In wild tobacco Nicotiana attenuata , co‐silencing NaMYC2a/b led to plants strongly impaired in their resistance to insect herbivores but with enhanced growth (Yang et al. 2023). All these findings strongly indicate the key role of MYC2s in JA‐induced defence and inhibition of plant growth. However, the molecular mechanisms underlying MYC2‐mediated defence over growth have not yet been fully uncovered. Ethylene response factors (ERFs) belong to the AP2/ERF family and have an AP2 DNA‐binding domain that can bind specifically to the GCC‐box cis‐regulatory element (Nakano et al. 2006; Wang et al. 2009; Licausi et al. 2013; Feng et al. 2020). Several reports have shown that ERFs play critical roles in modulating plant disease resistance or growth. In Arabidopsis, AtERF1 positively regulates plant resistance to several pathogens, including Botrytis cinerea, Plectosphaerella cucumerina, and Fusarium oxysporum, through the activation of defence‐related genes such as PDF and PR genes (Berrocal‐Lobo et al. 2002; Lorenzo et al. 2003; Berrocal‐Lobo and Molina 2004). Zarei et al. (2011) demonstrated in vitro that AtERF1 directly binds to two GCC‐box motifs within the promoter region of the disease resistance gene PDF1.2. Overexpression of tomato TERF1 (also known as SlERF1) in tobacco activated the expression of pathogen‐related genes containing GCC‐box and caused inhibition of plant growth (Huang et al. 2004). Tobacco NtERF5 positively regulates resistance to Tobacco mosaic virus by binding to the GCC‐box of PR genes (Fischer and Droge‐Laser 2004). The OsRPH1 in rice (also known as OsERF061) inhibits plant growth by modulating the expression of genes involved in the GA metabolic pathway (Ma et al. 2020). Currently, it remains unknown whether ERFs are involved in both JA‐induced disease resistance and inhibition of plant growth. Alternaria alternata is a necrotrophic fungal pathogen that infects Nicotiana species, including cultivated tobacco and wild diploid tobacco N. attenuata . JA signalling plays a key role in Nicotiana plants' resistance to A. alternata . When the JA biosynthetic gene AOC or the receptor gene COI1 was silenced, both N. attenuata and cultivated tobacco plants became highly susceptible to A. alternata (Sun et al. 2014; Long et al. 2021; Song and Wu 2024b). Scopoletin is a coumarin biosynthesized in plants through the phenylpropanoid pathway and is an important phytoalexin produced in Nicotiana plants (Sun et al. 2014; Song and Wu 2024a, 2024b). F6'H1 is a key enzyme gene involved in scopoletin biosynthesis (Kai et al. 2008; Sun et al. 2014). When N. attenuata is infected by A. alternata , scopoletin is highly induced. This induction mainly depends on the JA signalling (Sun et al. 2014). The key JA regulators NaMYC2a and NaMYC2b are critical for resistance against A. alternata . When NaMYC2a and NaMYC2b were transiently co‐silenced, both NaF6'H1 expression and scopoletin production were significantly reduced. Accordingly, plants became more susceptible to A. alternata (Song and Wu 2024a). However, the molecular mechanism underlying the regulation of scopoletin biosynthesis by NaMYC2a/b remains largely unclear. In this study, we identified an ERF transcription factor, NaERFIDOG, as a key downstream regulator of NaMYC2a and NaMYC2b, controlling both disease resistance against A. alternata and the inhibition of plant growth through scopoletin, JA, and GA. These findings uncovered a novel regulatory network of ‘JA‐induced defense over growth’, providing new insights into the molecular mechanisms underlying the trade‐off between defence and growth in plants. Result NaERFIDOG , a JA‐Dependent ERF Transcription Factor, Plays a Crucial Role in Nicotiana attenuata 's Resistance to the Fungal Pathogen Alternaria alternata Previously, we found that JA signalling plays a vital role in the biosynthesis of the phytoalexin scopoletin, as well as A. alternata resistance in N. attenuata (Sun et al. 2014; Song and Wu 2024a, 2024b). However, the regulation of these defence responses by JA remains unclear. To identify key regulators downstream of JA signalling, we performed RNA sequencing on the leaves of WT and JA‐deficient irAOC plants (silenced with NaAOC) after inoculation with A. alternata at 1 day post inoculation (dpi), and silenced the top five transcription factors via virus‐induced gene silencing (VIGS). Our results revealed that an ERF transcription factor exhibited the highest expression levels in response to A. alternata , while plants had the lowest expression level of NaF6'H1 when silenced (Figures S1 and S2, Figure 1A). This gene was named NaERF IDOG (ERF for ‘induction of defense over growth’), as we later discovered that it is required not only for disease resistance, but also for the inhibition of plant growth. The JA‐dependent NaERFIDOG plays a key role in regulating N. attenuata resistance to A. alternata . (A) Silencing NaERF IDOG by virus induced gene silencing (VIGS) reduced NaF6'H1 expression and A. alternata resistance. Mean (±SD) relative transcripts of NaERF IDOG (left panel) and NaF6'H1 (middle panel), and diameter of necrotic lesions (right panel) were measured in young leaves transformed with empty vector (EV) or VIGS construct (VIGS NaERF IDOG ) at 3 days post‐inoculation (dpi). Asterisks indicate significant differences between EV and VIGS plants (Student's t‐test: *p < 0.05; **p < 0.01; ***p < 0.001). (B, C) Mean (±SD) relative NaERF IDOG levels were measured in the source‐sink transition leaves (0 leaves) of WT at 1, 2, and 3 dpi, as well as in irAOC and irCOI1 plants at 2 dpi. Asterisks indicate significant differences between mock and infected samples in WT, as well as between WT and irAOC or irCOI1 plants (Student's t‐test: *p < 0.05; **p < 0.01; ***p < 0.001). (D) Nuclear localization of NaERFIDOG. 35S::GFP and 35S::NaERF IDOG ‐GFP were transiently expressed in N. attenuata protoplasts. Images were taken in bright field (BF) (left), UV (middle), and GFP channels (right). (E) Silencing of NaERF IDOG by RNA interference (RNAi) via stable transformation reduced N. attenuata resistance to A. alternata . Mean (±SD) relative expression levels of NaERF IDOG induced by A. alternata were measured in 0 leaves of WT and two independent NaERF IDOG ‐silenced lines (NaERF IDOG ‐RNAi‐3# and ‐4#) at 2 dpi (upper panel). Mean (±SD) diameter of necrotic lesions were measured in WT, NaERF IDOG ‐RNAi‐3#, and NaERF IDOG ‐RNAi‐4# lines at 3 dpi (lower panel). Asterisks indicate significant differences between WT and RNAi lines (Student's t‐test: **p < 0.01; ***p < 0.001). (F) Stable overexpression of NaERF IDOG (NaERF IDOG ‐OE) enhanced plant resistance to A. alternata . Mean (±SD) relative expression level of NaERF IDOG induced by A. alternata infection was measured in 0 leaves of WT and three independent NaERF IDOG ‐OE plants (NaERF IDOG ‐OE‐1#, ‐2#, and ‐3#) at 2 dpi (upper panel). Mean (±SD) diameter of necrotic lesions were measured in WT, NaERF IDOG ‐OE‐1#, NaERF IDOG ‐OE‐2#, and NaERF IDOG ‐OE‐3# lines at 3 dpi (lower panel). Asterisks indicate significant differences between WT and OE lines (Student's t‐test: **p < 0.01; ***p < 0.001). Multiple sequence alignment of NaERFIDOG with other ERFs revealed that it contains a highly conserved AP2/ERF domain (Figure S3). It is more closely related to NtERFC3‐like (unknown function), sharing 80% amino acid sequence identity (Figure S3). In response to A. alternata , the expression level of NaERF IDOG increased by more than 300‐fold at 1, 2, and 3 dpi in the source‐sink transition leaves of WT (Figure 1B). However, it decreased by 97.64% and 96.49%, respectively, in JA‐deficient irAOC and JA‐insensitive irCOI1 plants at 2 dpi (Figure 1C). NaERFIDOG was localized in the nucleus when 35S::NaERF IDOG ‐GFP was transiently overexpressed in the protoplasts of N. attenuata (Figure 1D). When NaERFIDOG was fused with the DNA‐binding domain of the GAL4 protein in yeast cells, robust self‐activation activity was observed (Figure S4A). Electrophoretic mobility shift assay (EMSA) and dual‐luciferase (Dual‐LUC) assay showed that NaERFIDOG binds to its own promoter and activates transcription (Figure S4B–D). These results suggest that NaERFIDOG acts as a transcription factor whose expression is induced by A. alternata in a JA‐dependent manner. To confirm the role of NaERFIDOG in A. alternata resistance, we successfully generated two independent N. attenuata lines that were stably silenced for NaERF IDOG (NaERF IDOG ‐RNAi‐3# and NaERF IDOG ‐RNAi‐4#). Compared with WT, the basal expression levels of NaERF IDOG were reduced by 70.63% and 91.10% in lines 3# and 4#, respectively. After A. alternata inoculation at 2 dpi, the expression levels of NaERF IDOG decreased by 98.87% and 96.31% in lines 3# and 4#, respectively (Figure 1E). These two RNAi lines were more susceptible to A. alternata , consistent with VIGS results, with larger lesions developing after inoculation (Figure 1A,E, Figure S5A). We also generated NaERF IDOG knockout mutants using the CRISPR/Cas9 system. We successfully obtained two mutant lines: NaERF IDOG ‐KO‐2#, which has insertions of a C and an A, and NaERF IDOG ‐KO‐7#, which has a 32 bp deletion (Figure S6A). Both mutations lead to premature termination of the coding sequence (Figure S6B). These two knockout lines are more susceptible to A. alternata , which is consistent with VIGS and RNAi results, with larger lesions developing after inoculation (Figure 1A,E, Figure S6C,D). To further characterize the role of NaERFIDOG, we also successfully generated three independent stable overexpression lines of NaERF IDOG . The levels of basal and A. alternata ‐induced NaERF IDOG expression increased significantly in all three overexpression lines (NaERF IDOG ‐OE‐1#, ‐2#, and ‐3#) compared to WT (Figure 1F). Consistently, these plants were more resistant to A. alternata , developing much smaller lesions after inoculation (Figure 1F, Figure S5B). Collectively, these results demonstrate that NaERFIDOG is a JA‐dependent regulator that is crucial for plant resistance to A. alternata in N. attenuata . NaERFIDOG Is Located Downstream of NaMYC2a/b and Is Directly Regulated by NaMYC2a/b During A. alternata Inoculation Our previous study revealed that the transcription factors NaMYC2a and NaMYC2b (NaMYC2a/b) did not directly regulate the expression of NaF6'H1 (Song and Wu 2024a). We hypothesized that NaERFIDOG is a key regulator downstream of NaMYC2a/b, directly controlling scopoletin biosynthesis. To test this hypothesis, we generated stable transformation lines that were co‐silenced with NaMYC2a/b (NaMYC2a/b‐RNAi‐1# and NaMYC2a/b‐RNAi‐2#) in a previous study (Zhao et al. 2025). The expression levels of NaMYC2a in NaMYC2a/b‐RNAi‐1# and NaMYC2a/b‐RNAi‐2# lines decreased by 75.08% and 37.15% at the basal level, and by 85.30% and 52.16% at 2 dpi, respectively (Figure 2A). Meanwhile, the expression levels of NaMYC2b decreased by 91.46% and 22.81% at the basal level, and by 95.28% and 36.03% at 2 dpi (Figure 2A). These results indicated that NaMYC2a and NaMYC2b were successfully co‐silenced. Interestingly, basal NaERF IDOG expression levels in these two transgenic lines were reduced by 74.93% and 56.53%, respectively. After inoculation with A. alternata at 2 dpi, expression levels decreased further, by 93.74% and 84.15%, respectively, compared to the WT (Figure 2A). As expected, NaMYC2a/b‐RNAi‐1# and NaMYC2a/b‐RNAi‐2# plants were more susceptible to A. alternata , developing larger lesions after inoculation (Figure 2A, Figure S7A). The master regulators of JA signalling, NaMYC2a/b, directly control NaERFIDOG expression, and overexpression of NaERF IDOG enhances resistance to A. alternata in plants co‐silenced for NaMYC2a/b. (A) Co‐silencing NaMYC2a/b dramatically reduced basal and A. alternata ‐induced NaERF IDOG expression and A. alternata resistance. Mean (±SD) relative expression levels of NaMYC2a, NaMYC2b, and NaERF IDOG (2 dpi), and diameter of necrotic lesions (3 dpi) were measured in 0 leaves of WT and two independent NaMYC2a/b‐silenced plants (NaMYC2a/b‐RNAi‐1# and ‐2#). Asterisks indicate significant differences between WT and RNAi lines (Student's t‐test: *p < 0.05; **p < 0.01; ***p < 0.001). (B) Schematic representation of the NaERF IDOG promoter, showing probes containing G‐box motifs (probe1, 2, and 3) for use in EMSA and DNA regions (P1 + P2, P3, and P4) amplified for ChIP‐qPCR. (C) ChIP‐qPCR was performed using plants transiently overexpressing 35S::NaMYC2a/b‐HA and inoculated with A. alternata for 2 days to detect the in vivo binding of NaMYC2a/b to the NaERF IDOG promoter. More DNA fragments of P1 + P2 and P3 (with G‐boxes), but not P4 (without G‐box as negative control), were enriched when chromatins were precipitated with HA antibody. Immunoglobulin G (IgG) antibody immunoprecipitated samples were used as negative controls. Asterisks indicate significant differences between negative control and experimental groups (Student's t‐test: *p < 0.05). ns, not significant. (D) EMSA results showing the binding of NaMYC2a/b‐GST to the probes designed from the NaERF IDOG promoter. The NaMYC2a‐GST (upper panel) and NaMYC2b‐GST (lower panel) proteins were incubated with biotin‐labelled probes to detect binding capacity. 5‐, 10‐, 20‐, 50‐, and 200‐fold excess of unlabeled probes were used as cold competitors. Mutant probes (Biotin‐mProbse) and GST protein were used as negative controls. (E) Schematic representation of vectors used for Dual‐LUC assays. The effector vectors contain the NaMYC2a/b coding sequence fused with GFP or GFP only (as control). The reporter vector has the NaERF IDOG promoter, which drives luciferase (LUC) expression. Renilla luciferase (REN) was driven by the 35S promoter as an internal control. (F) The Dual‐LUC assays showed that NaMYC2a/b overexpression activates the transcriptional activity of the NaERF IDOG promoter. Mean (±SD) relative NaMYC2a (left panel) and NaMYC2b (middle panel) transcripts were measured in N. attenuata leaves transiently overexpressing NaMYC2a/b or EV (GFP as control). The LUC/REN ratio of NaERF IDOG pro indicated the activation of the NaERF IDOG promoter by overexpressing NaMYC2a/b (right panel). (Student's t‐test: ***p < 0.001). (G) Overexpression of NaERF IDOG increased A. alternata resistance in NaMYC2a/b‐RNAi lines. Mean (±SD) relative expression levels of NaERF IDOG (at 2 dpi), and diameter of necrotic lesions (at 3 dpi) were measured in 0 leaves of WT, NaMYC2a/b‐RNAi‐1#, NaMYC2a/b‐RNAi‐1#/NaERF IDOG ‐OE‐1#, NaMYC2a/b‐RNAi‐1#/NaERF IDOG ‐OE‐2#, NaERF IDOG ‐OE‐1#, and NaERF IDOG ‐OE‐2# lines. Asterisks indicate significant differences among WT and transgenic lines (Student's t‐test: **p < 0.01; ***p < 0.001). Different letters indicate significant differences by one‐way ANOVA followed by Duncan's test (p < 0.05). We also generated NaMYC2a/b co‐knockout mutants in N. attenuata using CRISPR/Cas9. We successfully obtained two mutant lines: NaMYC2a/b‐KO‐4#, in which NaMYC2a has a 22 bp deletion and NaMYC2b has a 1 bp deletion; NaMYC2a/b‐KO‐5#, in which NaMYC2a has a T insertion and NaMYC2b has a 1 bp deletion (Figure S8A). Both co‐knockout mutations lead to premature termination of the coding sequence (Figure S8B). Consistent with the results in the RNAi lines, the expression levels of NaERF IDOG were significantly reduced in NaMYC2a/b knockout mutants both under basal conditions and after inoculation with A. alternata (Figure S8C, Figure 2A). These two knockout lines were also more susceptible to A. alternata, with larger lesions developing after inoculation (Figure S8D,E, Figure 2A). We conducted chromatin immunoprecipitation coupled with quantitative PCR (ChIP‐qPCR) and EMSA to test whether NaMYC2a/b could directly bind to the promoter of NaERF IDOG in vivo and in vitro. The ChIP‐qPCR results showed that in leaf samples transiently transformed with 35S::NaMYC2a/b‐HA, after inoculation with A. alternata for 2 days, DNA fragments containing G‐box motifs in the P1 + P2 and P3 regions were significantly enriched upon immunoprecipitation with an anti‐HA antibody. In contrast, neighbouring regions (P4) of the promoter without a GCC‐box motif did not show significant enrichment (Figure 2B,C). EMSA revealed that the NaMYC2a/b‐GST bound specifically to probes 1, 2, and 3. Binding signals were reduced or disappeared when 5‐, 10‐, 20‐, 50‐, or 200‐fold unlabeled cold probes were added. When the core sequence of G‐box was mutated, the NaMYC2a‐GST and NaMYC2b‐GST proteins could no longer bind to these probes (Figure 2B,D). These results indicate that the NaMYC2a/b protein can bind specifically to the G‐box within the NaERF IDOG promoter in vivo and in vitro. Further Dual‐LUC assays revealed that the NaERF IDOG promoter was activated when NaMYC2a/b were co‐overexpressed, as indicated by the increased LUC/REN ratio (Figure 2E,F). To confirm that NaERFIDOG is located downstream of NaMYC2a/b, we hypothesized that overexpression of NaERF IDOG could rescue the resistant phenotype in plants co‐silenced with NaMYC2a/b. We thus crossed the NaMYC2a/b‐RNAi lines with the NaERF IDOG overexpression lines to produce the NaMYC2a/b‐RNAi/NaERF IDOG ‐OE (1#/1# and 1#/2#) lines. In these plants, NaMYC2a and NaMYC2b were confirmed to be co‐silenced and NaERF IDOG was overexpressed (Figure 2G, Figure S7B,C). Further analysis revealed that the NaMYC2a/b‐RNAi‐1# parent line exhibited significantly larger lesions, whereas the crossing lines had smaller lesions similar to NaERF IDOG overexpression lines, indicating that resistance to A. alternata had been restored (Figure 2G, Figure S7D). Collectively, these results demonstrate that NaERFIDOG is located downstream of NaMYC2a/b in the JA‐regulated defence responses to A. alternata . NaMYC2a/b regulates NaERF IDOG expression by binding directly to its promoter and activating transcription during A. alternata inoculation. NaMYC2a/b Inhibits the Growth of N. attenuata Through NaERFIDOG When 30‐day‐old N. attenuata plants at the rosette stage were treated with 10 μM MeJA for 20 days, the rosette diameters of the treated plants were significantly reduced (Figure S9A,B). In contrast, the rosette diameters of JA‐deficient irAOC (silenced with NaAOC) or JA‐insensitive irCOI1 (silenced with NaCOI1) plants were significantly larger than those of WT plants (Figure S9C,D). Here, we also showed that NaMYC2a/b‐RNAi and NaMYC2a/b‐KO lines grew larger than WT (Figure 3, Figure S10). These results confirmed that activation of JA signalling inhibits the growth of N. attenuata . Plants silenced with either NaERF IDOG or NaMYC2a/b grow bigger. However, stable overexpression of NaERF IDOG reduces the growth of both WT plants and those co‐silenced with NaMYC2a/b to a similar level. Photograph (A) and mean (±SD) rosette diameter (B) of 40‐day‐old N. attenuata plants of WT, NaMYC2a/b‐RNAi (1# and 2#), NaERF IDOG ‐RNAi (3# and 4#), NaERF IDOG ‐OE (1#, 2#, and 3#), NaMYC2a/b‐RNAi‐1#/NaERF IDOG ‐OE‐1# and NaMYC2a/b‐RNAi‐1#/NaERF IDOG ‐OE‐2# lines. Asterisks indicate significant differences among WT and transgenic lines. Different letters indicate significant differences by one‐way ANOVA followed by Duncan's test (p < 0.05). To investigate the role of NaERFIDOG in JA‐mediated growth inhibition, we systematically investigated the growth phenotypes of WT, NaMYC2a/b‐RNAi lines (1# and 2#), NaERF IDOG ‐RNAi lines (3# and 4#), NaERF IDOG ‐OE lines (1#, 2#, and 3#), and NaMYC2a/b‐RNAi/NaERF IDOG ‐OE lines (1#/1# and 1#/2#). Our results showed that the rosette diameters of the NaERF IDOG ‐RNAi lines were comparable to those of the NaMYC2a/b‐RNAi lines, but were significantly larger than the WT plants (Figure 3A,B). These results were further confirmed by NaMYC2a/b and NaERF IDOG knockout mutants (Figure S10A,B), which showed that NaERFIDOG's role in growth inhibition is only slightly smaller than that of NaMYC2a/b. The three NaERF IDOG ‐OE lines exhibited clear growth inhibition, as evidenced by significantly smaller rosette diameters than the WT (Figure 3A,B). Notably, the rosette diameters of NaMYC2a/b‐RNAi‐1# plants decreased to the same level as those of NaERF IDOG ‐OE‐1# and ‐2# plants when they were crossed (Figure 3A,B). These results indicate that the overexpression of NaERF IDOG can suppress the growth of NaMYC2a/b‐RNAi‐1# plants. This supports that NaERFIDOG is located downstream of NaMYC2a/b in the JA‐induced growth inhibition. NaERFIDOG Elicits Scopoletin and JA Biosynthesis to Regulate Both the Growth and Disease Resistance of N. attenuata In N. attenuata , NaF6'H1 is a key enzyme gene for the biosynthesis of scopoletin induced by A. alternata (Sun et al. 2014; Song and Wu 2024b). Transcriptome analysis showed that the expression level of A. alternata ‐induced NaF6'H1 was dramatically reduced in the NaERF IDOG ‐silenced lines compared to WT (Figure 4A,B). To verify this result, we performed qPCR to detect the expression level of NaF6'H1 in the NaERF IDOG ‐RNAi‐3# and ‐4# lines. Under mock treatment, the expression levels of NaF6'H1 were reduced by 92.43% and 88.36%, respectively, compared to WT. After A. alternata inoculation, the expression levels of NaF6'H1 were reduced by 97.99% and 95.42%, respectively (Figure 4C). Further analysis revealed that A. alternata ‐induced scopoletin levels were significantly lower in both NaERF IDOG ‐silenced lines (RNAi‐3# and RNAi‐4#) than in WT (Figure 4C). Similarly, the expression levels of NaF6'H1 were also significantly reduced in both NaERF IDOG knockout mutants under both basal conditions and after inoculation with A. alternata (Figure S11). NaERFIDOG regulates scopoletin biosynthesis by directly controlling NaF6'H1 expression. (A) Schematic diagrams of the scopoletin biosynthetic pathway. The key enzyme F6'H1 is written in red. (B) Heat map showing the expression of genes involved in scopoletin and JA biosynthesis, as well as JA signalling in 0 leaves of WT and NaERF IDOG ‐RNAi‐3# plants at 2 dpi. (C) A. alternata ‐induced NaF6'H1 expression and scopoletin biosynthesis were severely reduced in NaERF IDOG ‐silenced plants. Mean (±SD) relative expression level of NaF6'H1 (left panel, 2 dpi) and scopoletin (right panel, 3 dpi) were measured in 0 leaves of WT and two independent NaERF IDOG ‐silenced plants (NaERF IDOG ‐RNAi‐3# and ‐4#). Asterisks indicate significant differences between WT and RNAi lines (Student's t‐test: *p < 0.05; **p < 0.01; ***p < 0.001). (D) Schematic representation of the NaF6'H1 promoter, showing probes containing GCC‐box motifs (probe1 and 2) for used in EMSA, and DNA regions (P1 + P2, and P3) amplified for ChIP‐qPCR. (E) ChIP‐qPCR was performed using a stable NaERF IDOG ‐HA overexpression line inoculated with A. alternata for 2 days to detect the in vivo binding of NaERFIDOG to the NaF6'H1 promoter. More DNA fragments of P1 + P2 (with GCC‐boxes), but not P3 (without GCC‐box as control), were enriched when chromatins were precipitated with HA antibody. Immunoglobulin G (IgG) antibody immunoprecipitated samples were used as negative controls. Asterisks indicate significant differences between negative control and experimental groups (Student's t‐test: ***p < 0.001). ns, not significant. (F) EMSA results showing the binding of NaERFIDOG‐GST to probe1 and 2 from NaF6'H1 promoter. The NaERFIDOG‐GST proteins were incubated with a biotin‐labelled probes to detect binding capacity. 5‐, 10‐, 20‐, 50‐, and 200‐fold excess of unlabeled probes was used as cold competitors. Mutant probes (Biotin‐mProbse) and GST were used as negative controls. (G) Schematic representation of vectors used for Dual‐LUC assays. The effector vectors contain the NaERFIDOG coding sequence fused with GFP or GFP only (as negative control). The reporter vector has the NaF6'H1 promoter, which drives LUC expression. REN was driven by the 35S promote as an internal control. (H) The Dual‐LUC assays indicated NaERF IDOG overexpression activates NaF6'H1 promoter. Mean (±SD) relative NaERF IDOG (left panel) transcript was measured in N. attenuata leaves transiently overexpressing NaERF IDOG or EV (GFP as control). The LUC/REN ratio of NaF6'H1pro indicated the activation of NaF6'H1 promoter by overexpression of NaERF IDOG (right panel). (Student's t‐test: **p < 0.01). ChIP‐qPCR results revealed in vivo binding of NaERFIDOG‐HA to the NaF6'H1 promoter, as DNA regions (P1 + P2) containing GCC‐box motif were significantly enriched when leaf samples were immunoprecipitated with an anti‐HA antibody. In contrast, neighbouring regions (P3) of the promoter without a GCC‐box motif did not show significant enrichment (Figure 4D,E). Next, EMSA was performed using the NaERFIDOG‐GST fusion protein and biotin‐labelled probes that were designed based on the NaF6'H1 promoter region (P1 and P2) containing GCC‐box (Figure 4D). Our results revealed that the NaERFIDOG‐GST protein bound specifically to probe 1 and 2. However, this binding signal decreased or disappeared when excesses of unlabeled cold probes (5‐, 10‐, 20‐, 50‐, or 200‐fold) were added. When the GCC‐box core sequence was mutated, the NaERFIDOG‐GST protein was unable to bind to probe 1 and 2 (Figure 4F). We further used Dual‐LUC assays to analyse the activation of NaERFIDOG on the NaF6'H1 promoter. Our results showed that transient overexpression of NaERF IDOG in N. attenuata significantly increased the LUC/REN ratio (Figure 4G,H), indicating that NaERFIDOG activates the NaF6'H1 promoter's transcriptional activity. Unexpectedly, we discovered that the biosynthesis of scopoletin affects plant growth. The rosette diameter of WT plants was significantly reduced after 20 days treatment with exogenous scopoletin (Figure S12A,B). Furthermore, NaF6'H1‐silenced plants grew larger than WT (Figure S12C,D). Thus, our data revealed that scopoletin biosynthesis is involved not only in disease resistance, but also in the negative regulation of N. attenuata growth. Transcriptomic analysis revealed that the expression of several JA‐related genes was significantly lower in the NaERF IDOG ‐RNAi‐3# line than in the WT (Figures 4B and 5A). These include the JA biosynthesis genes NaAOS and another two candidate genes for JA biosynthesis, NaOPR2 and NaJAR1. In contrast, the expression levels of the JA repressor genes (NaJAZa, NaJAZc, NaJAZf, NaJAZh, and NaJAZj) were significantly higher in the NaERF IDOG ‐RNAi‐3# line (Figure 4B). The expression pattern of these JA‐related genes was confirmed by qPCR in WT, NaERF IDOG ‐RNAi‐3#, and NaERF IDOG ‐RNAi‐4# lines (Figure 5B, Figures S13A and S14). Consequently, A. alternata ‐induced JA and JA‐Ile were reduced in both NaERF IDOG ‐RNAi lines (Figure 5C). Consistently, the expression levels of NaAOS, NaOPR2, and NaJAR1 were also significantly reduced in NaERF IDOG knockout mutants after inoculation with A. alternata (Figure S11). NaERFIDOG regulates JA biosynthesis by directly controlling the expression of NaAOS. (A) Schematic diagrams of the JA biosynthetic pathway. The key enzyme AOS is written in red. (B) Mean (±SD) relative expression levels of NaAOS were measured in 0 leaves of WT and two independent NaERF IDOG ‐silenced plants (NaERF IDOG ‐RNAi‐3# and ‐4#) at 2 dpi. Asterisks indicate significant differences between WT and RNAi lines (Student's t‐test: **p < 0.01; ***p < 0.001). (C) Mean (±SD) JA and JA‐Ile levels were determined by HPLC‐MS/MS in 0 leaves from WT and two independent NaERF IDOG ‐silenced plants (NaERF IDOG ‐RNAi‐3# and ‐4#) at 2 dpi. Asterisks indicate significant differences between WT and RNAi lines (Student's t‐test: *p < 0.05; **p < 0.01). ns, not significant. (D) Schematic representation of the NaAOS promoter, showing probes containing GCC‐box motifs (probe1) for used in EMSA, and DNA regions (P1 and P2) amplified for ChIP‐qPCR. (E) ChIP‐qPCR was performed using a stable NaERF IDOG ‐HA overexpression line inoculated with A. alternata for 2 days to detect the in vivo binding of NaERFIDOG to the NaAOS promoter. More DNA fragments of P1 (with GCC‐box), but not P2 (without GCC‐box as control), were enriched when chromatins were precipitated with HA antibody. Immunoglobulin G (IgG) antibody immunoprecipitated samples were used as negative controls. Asterisks indicate significant differences between negative control and experimental groups (Student's t‐test: **p < 0.01). ns, not significant. (F) EMSA results showing the binding of NaERFIDOG‐GST to probe1 from NaAOS promoter. The NaERFIDOG‐GST proteins were incubated with a biotin‐labelled probes to detect binding capacity. 5‐, 10‐, 20‐, 50‐, and 200‐fold excess of unlabeled probes was used as cold competitors. Mutant probes (Biotin‐mProbse) and GST were used as negative controls. (G) Schematic representation of vectors used for Dual‐LUC assays. The effector vectors contain the NaERFIDOG coding sequence fused with GFP or GFP only (as negative control). The reporter vector has the NaAOS promoter, which drives LUC expression. REN was driven by the 35S promote as an internal control. (H) The Dual‐LUC assays indicated NaERF IDOG overexpression activates NaAOS promoter. Mean (±SD) relative NaERF IDOG (left panel) transcript was measured in N. attenuata leaves transiently overexpressing NaERF IDOG or EV (GFP as control). The LUC/REN ratio of NaAOSpro indicated the activation of NaAOS promoter by overexpression of NaERF IDOG (right panel). (Student's t‐test: *p < 0.05; ***p < 0.001). ChIP‐qPCR and EMSA results showed the in vivo and in vitro binding of NaERFIDOG to the promoters of NaAOS, NaOPR2, and NaJAR1 (Figure 5D–F, Figure S13B–D). Further Dual‐LUC assays indicated that transient overexpression of NaERF IDOG in N. attenuata significantly enhanced the promoter activities of NaAOS, NaOPR2, and NaJAR1 (Figure 5G,H, Figure S13E,F). These findings support the idea that NaERFIDOG binds directly to and activates NaF6'H1, NaAOS, NaOPR2, and NaJAR1, thereby increasing the production of scopoletin and JA. NaERFIDOG Inhibits GA Biosynthesis to Regulate Both the Growth and Disease Resistance of N. attenuata When inoculated with A. alternata , the levels of active gibberellins GA1 and GA3 were significantly reduced in WT leaves (Figure S15A). This result implies that the GA pathway is involved in the defence response to the fungal pathogen. Indeed, increased lesion size was observed in leaves pre‐treated with GA3 when inoculated with A. alternata , but decreased when pre‐treated with the gibberellin biosynthesis inhibitor paclobutrazol (PAC) (Figure S15B,C). However, how GA biosynthesis is inhibited by A. alternata infection is unclear. Transcriptomic analysis revealed altered expression of GA‐related genes in the NaERF IDOG ‐RNAi‐3# line at 2 dpi. The line exhibited higher expression levels of the GA biosynthetic candidate genes, such as NaKAO1‐like, NaGA20ox1‐like, and NaGA3ox1‐like, but lower expression levels of the GA degradation candidate genes, including NaGA2ox2‐like and NaGA2ox8‐like, and the negative regulator candidate gene NaGAI‐like (Figure 6A,B). These expression patterns of GA‐related genes were confirmed by qPCR in both NaERF IDOG ‐RNAi‐3# and NaERF IDOG ‐RNAi‐4# lines (Figure 6C, Figure S16). Further analysis showed that both GA1 and GA4 levels were significantly increased in NaERF IDOG ‐RNAi‐3# plants at 2 dpi (Figure 6D). NaERFIDOG regulates GA biosynthesis by directly controlling the expression of NaKAO1‐like. (A) Schematic diagrams of the GA biosynthetic pathway. The key enzyme KAO is written in red. (B) Heat map showing the expression of genes involved in GA biosynthesis and signalling in 0 leaves of WT and NaERF IDOG ‐RNAi‐3# plants at 2 dpi. (C) Mean (±SD) relative expression levels of NaKAO1‐like were measured in 0 leaves of WT and NaERF IDOG ‐RNAi‐3# and ‐4# lines at 2 dpi. Asterisks indicate significant differences between WT and RNAi lines (Student's t‐test: *p < 0.05; **p < 0.01; ***p < 0.001). (D) Mean (±SD) GA1 and GA4 levels were determined by HPLC‐MS/MS in 0 leaves from WT and NaERF IDOG ‐RNAi‐3# line at 2 dpi. Asterisks indicate significant differences between WT and RNAi lines (Student's t‐test: **p < 0.01; ***p < 0.001). (E) Mean (±SD) basal GA4 level were determined by HPLC‐MS/MS in 0 leaves from WT and NaERF IDOG ‐RNAi‐3# line. Asterisks indicate significant differences between WT and RNAi line (Student's t‐test: *p < 0.05). (F) Mean (±SD) relative expression levels of NaKAO1‐like (left panel, 2 dpi), rosette diameter (middle panel, 40‐day‐old) and diameter of necrotic lesions (right panel, 3 dpi) were measured in 0 leaves of WT and two independent NaKAO1‐like‐OE plants (NaKAO1‐like‐OE‐8# and ‐9#). Asterisks indicate significant differences between WT and OE lines (Student's t‐test: **p < 0.01; ***p < 0.001). (G) Schematic representation of the NaKAO1‐like promoter, showing probes containing GCC‐box motifs (probe1, 2 and 3) for used in EMSA, and DNA regions (P1, P2, P3 and P4) amplified for ChIP‐qPCR. (H) ChIP‐qPCR was performed using a stable NaERF IDOG ‐HA overexpression line inoculated with A. alternata for 2 days to detect the in vivo binding of NaERFIDOG to the NaKAO1‐like promoter. More DNA fragments of P1, P2 and P3 (with GCC‐boxes), but not P4 (without GCC‐box as negative control), were enriched when chromatins were precipitated with HA antibody. Immunoglobulin G (IgG) antibody immunoprecipitated samples were used as negative controls. Asterisks indicate significant differences between negative control and experimental groups (Student's t‐test: *p < 0.05). ns, not significant. (I) EMSA results showing the binding of NaERFIDOG‐GST to probe1 from NaKAO1‐like promoter. The NaERFIDOG‐GST proteins were incubated with a biotin‐labelled probes to detect binding capacity. 5‐, 10‐, 20‐, 50‐, and 200‐fold excess of unlabeled probes was used as cold competitors. Mutant probes (Biotin‐mProbse) and GST were used as negative controls. Interestingly, the basal expression levels of NaKAO1‐like, NaGA20ox1‐like, and NaGA3ox1‐like were significantly higher in both NaERF IDOG ‐silenced lines than in the WT (Figure 6C, Figure S16). Conversely, the expression of the GA degradation enzyme genes NaGA2ox8‐like and negative regulator gene NaGAI‐like was significantly lower (Figure S16). Consistently, the basal level of the bioactive gibberellin GA4 was significantly elevated in the NaERF IDOG ‐RNAi‐3# line compared to WT (Figure 6E). We also observed higher expression levels of NaKAO1‐like in NaERF IDOG knockout mutants under both basal conditions and after inoculation with A. alternata (Figure S11). These results demonstrate that NaERFIDOG negatively regulates GA biosynthesis at both the basal and A. alternata ‐induced levels. To confirm the role of NaKAO1‐like in GA biosynthesis, we generated two stable transgenic lines overexpressing NaKAO1‐like (NaKAO1‐like‐OE‐8# and ‐9#). Basal expression levels of NaKAO1‐like were upregulated by 361‐ and 270‐fold in NaKAO1‐like‐OE‐8# and ‐9# lines, respectively (Figure 6F). Consistently, the levels of the bioactive gibberellin GA4 were significantly elevated in the NaKAO1‐like‐OE‐8# line (Figure S17A), and the rosette diameter of the overexpression lines was significantly larger than that of the WT (Figure 6F, Figure S17B). These results demonstrated that NaKAO1‐like is indeed a GA biosynthetic gene. After inoculation with A. alternata , the expression levels of NaKAO1‐like in the overexpression lines NaKAO1‐like‐OE‐8# and ‐9# were upregulated by 15‐ and 14‐fold, respectively (Figure 6F). Both lines were more susceptible to A. alternata than WT, with larger lesions developing in these two lines (Figure 6F, Figure S17C). ChIP‐qPCR and EMSA revealed that NaERFIDOG binds directly to the NaKAO1‐like promoter in both in vivo and in vitro (Figure 6G–I). Dual‐LUC assays revealed that transient overexpression of NaERF IDOG in N. attenuata significantly inhibited the promoter activities of NaKAO1‐like (Figure S18), indicating that NaERFIDOG directly negatively regulates the expression of NaKAO1‐like. We have found that NaERFIDOG regulates JA and scopoletin biosynthesis, both of which are involved in the inhibition of plant growth. In order to rule out the interference of JA and scopoletin, we also investigated the suppression of GA biosynthesis by NaERFIDOG in JA‐deficient irAOC and JA‐insensitive irCOI1 plants. Our results showed that transient overexpression of NaERF IDOG ‐GFP could significantly reduce GA4 levels in WT, irAOC and irCOI1 plants (Figure S19). Considering that NaERFIDOG directly binds to and represses the NaKAO1‐like promoter (Figure 6G–I, Figure S18), we concluded that NaERFIDOG can suppress GA biosynthesis independent of JA. Collectively, these results indicated that NaERFIDOG suppresses GA biosynthesis through NaKAO1‐like and other GA‐related genes, thereby inhibiting plant growth and enhancing A. alternata resistance in N. attenuata . Discussion JA is a key phytohormone that regulates plant resistance to pathogens and herbivores by activating a series of defence‐related genes (Wasternack and Hause 2013; Wasternack and Strnad 2016). Meanwhile, JA treatment or activation of the JA signalling usually inhibits plant growth (Yang et al. 2012; Liu et al. 2021; He et al. 2022). This JA‐induced defence and growth inhibition is one of the important mechanisms of the trade‐off between defence and growth in plants. However, the underlying mechanisms remain largely unknown. Our studies demonstrate that NaERFIDOG is a key downstream regulator of NaMYC2a/b, activating the defence response against A. alternata and inhibiting growth in N. attenuata . This has led to the identification of a new ‘JA‐induced defense over growth’ pathway, JA‐MYC2‐ERFIDOG‐Scopoletin/JA/GA (Figure 7), thus providing new insight into the trade‐off between defence and growth. A working model showing how NaERFIDOG modulates defence responses against A. alternata and inhibits the growth of N. attenuata . When infected by A. alternata , N. attenuata activates JA signalling. The transcription factors NaMYC2a/b then directly regulate the expression of NaERF IDOG . Once activated, NaERFIDOG regulates JA‐induced defence responses and growth inhibition by controlling the biosynthesis of the phytohormones JA and GA, as well as the phytoalexin scopoletin. NaERFIDOG binds directly to and activates the biosynthetic genes of JA (NaAOS) and scopoletin (NaF6'H1), while suppressing those of GA (NaKAO1‐like). This results in higher levels of JA and scopoletin, and lower levels of GA, which finally leads to N. attenuata plants being more resistant to the fungus and inhibits the growth of plants. NaERFIDOG Is Located Downstream of NaMYC2a/b and Regulates JA‐Induced Defence Over Growth Several reports have demonstrated the pivotal role of MYC2 in JA‐induced defence and growth inhibition (Major et al. 2017; Jin et al. 2023; Yang et al. 2023). However, the mechanism by which MYC2s induce defence over growth has not been well elucidated. When rice is attacked by brown planthoppers, MYC2 can directly bind to the promoter of the GA degrading enzyme gene (GA2ox) to activate its expression, thereby repressing the synthesis of active GA and ultimately inhibiting the growth of rice (Jin et al. 2023). Here, our results supported a different mechanism by which NaMYC2a/b induce defence and inhibit plant growth through NaERFIDOG. NaMYC2a/b plays a key role in defence against A. alternata and growth inhibition in N. attenuata . Indeed, NaMYC2a/b‐RNAi and NaMYC2a/b‐KO lines were highly susceptible to A. alternata (Figure 2A, Figure S8D,E) and grew much larger than WT (Figure 3, Figure S10). We then demonstrated that A. alternata ‐induced expression of NaERF IDOG is directly regulated by NaMYC2a/b. The A. alternata ‐induced expression of NaERF IDOG was dramatically reduced in JA‐deficient irAOC and JA‐insensitive irCOI1 plants (Figure 1C). Next, analysis of NaMYC2a/b RNAi and knockout lines showed that NaERF IDOG expression was regulated by NaMYC2a/b (Figure 2A, Figure S8A–C). Moreover, NaMYC2a/b binds to the G‐box in the promoter region of NaERF IDOG and activates its expression, as demonstrated by ChIP‐qPCR, EMSA, and Dual‐LUC assays (Figure 2B–F). Interestingly, the binding of MYC2a/b to the NaERF IDOG promoter is enhanced after A. alternata infection (Figure S20). However, the reason is unclear. To support that NaERFIDOG acts downstream of NaMYC2a/b, we investigated defence responses and growth phenotype in NaMYC2a/b‐RNAi lines overexpressing NaERF IDOG and NaERF IDOG knockout mutant overexpressing NaMYC2a/b. Overexpression of NaERF IDOG increased the resistance of NaMYC2a/b‐RNAi lines to the fungus to a level comparable with that of the NaERF IDOG overexpression lines (Figure 2G). Moreover, the up‐regulation of NaF6'H1 expression and enhanced resistance caused by the overexpression of NaMYC2a/b disappeared in the NaERF IDOG ‐KO‐7# line (Figure S21). These results strongly support that NaERFIDOG is located downstream of NaMYC2a/b in the JA‐induced defence against A. alternata . Notably, the growth of the NaERF IDOG ‐RNAi and NaERF IDOG ‐KO lines is similar to that of the NaMYC2a/b‐RNAi and NaMYC2a/b‐KO lines, but much larger than that of WT (Figure 3, Figure S10), suggesting that NaERFIDOG plays a similar role to NaMYC2a/b in growth inhibition. The role of NaERFIDOG in growth inhibition was further supported by the NaERF IDOG ‐OE lines. All three lines exhibited clear growth inhibition, with significantly smaller rosette diameters than the WT (Figure 3). Importantly, the rosette diameters of NaMYC2a/b‐RNAi lines decreased to the same level as those of NaERF IDOG ‐OE lines when the two transgenic lines were crossed (Figure 3). Moreover, NaMYC2a/b‐suppressed NaKAO1‐like expression was also abolished in the NaERF IDOG ‐KO‐7# line (Figure S21). These results support that NaERFIDOG is located downstream of NaMYC2a/b in the JA‐induced growth inhibition. NaERFIDOG Regulates Scopoletin and JA Biosynthesis Previously, we found that phytoalexin scopoletin is a defence chemical produced in N. attenuata against A. alternata , and its biosynthesis is completely dependent on the JA signal (Sun et al. 2014; Song and Wu 2024a, 2024b). Later, it was reported that A. alternata ‐induced NaF6'H1 expression was largely dependent on NaMYC2a/b, however, NaMYC2a/b did not bind to the G‐box motif in the promoter region of NaF6'H1 (Song and Wu 2024a). Here, we discovered NaERFIDOG as a key regulatory factor involved in scopoletin biosynthesis. A. alternata ‐induced NaF6'H1 expression was dramatically reduced in NaERF IDOG ‐RNAi lines, and NaERFIDOG directly binds to the promoter of NaF6'H1 and activates its transcription as shown by ChIP‐qPCR, EMSA, and Dual‐LUC assays (Figure 4). Interestingly, we found that scopoletin biosynthesis negatively affected plant growth. This is supported by the observation that scopoletin treatment inhibited plant growth, while silencing NaF6'H1 enhanced growth (Figure S12). Since both basal and A. alternata ‐induced NaF6'H1 expression depend on NaERFIDOG, we reasoned that NaERFIDOG inhibits plant growth, at least in part, through scopoletin. Previous studies have reported the feedback regulation of JA by NaWRKY70 during A. alternata infection in N. attenuata (Song and Wu 2024b). Similarly, our findings revealed that NaERFIDOG also regulates JA biosynthesis, although its expression, both basal and A. alternata ‐induced, was largely dependent on the JA signalling. In N. attenuata , NaAOS has been established as a key gene involved in JA biosynthesis (Ziegler et al. 2001; Halitschke et al. 2004), whereas the functional roles of NaOPR2 and NaJAR1 remain to be fully elucidated. NaERF IDOG ‐RNAi plants decreased the expression of the JA biosynthetic gene NaAOS and two other candidate genes, NaOPR2 and NaJAR1, as well as the production of JA and JA‐Ile (Figure 5A–C, Figure S13A). Consistently, their expression was also decreased in NaERF IDOG ‐KO plants (Figure S11). Moreover, ChIP‐qPCR, EMSA, and Dual‐LUC assays revealed that NaERFIDOG binds to the GCC‐box in the promoter regions of NaAOS, NaOPR2, and NaJAR1 and activates their transcription activity (Figure 5D–H, Figure S13B–F). We also showed that plants with impaired JA biosynthesis or signalling (NaAOC‐RNAi, NaCOI1‐RNAi, NaMYC2a/b‐RNAi, and NaMYC2a/b‐KO lines) grow larger than WT (Figure 3, Figure S10), thus indicating that increasing JA production is another way in which NaERFIDOG inhibits plant growth. NaERFIDOG Suppress GA Biosynthesis Although GA is initially known as a plant growth hormone, more and more evidence shows that it also participates in plant defence against pathogens (Navarro et al. 2008). Consistently, we found that GA levels decreased after A. alternata inoculation, and that N. attenuata plants became more susceptible to this fungus when their leaves were pre‐treated with GA (Figure S15). However, the plants were more resistant when treated with PAC (Figure S15). Currently, how GA biosynthesis is inhibited by A. alternata infection is unclear. It is likely suppressed by the activation of JA signalling after pathogen attack, through MYC2, and the interaction of DELLA and JAZ (Yang et al. 2012; Jin et al. 2023). Our data strongly support the idea that the JA‐dependent NaERFIDOG plays a critical role in the inhibition of GA biosynthesis during infection. NaERF IDOG ‐RNAi and knockout lines had higher expression levels of GA biosynthetic genes and lower levels of degrading enzyme genes (Figure 6A–C, Figures S11 and S16). Consistently, the NaERF IDOG ‐RNAi line had a higher level of GA (Figure 6D,E). Particularly, the role of NaKAO1‐like as a key enzyme gene of GA biosynthesis was further confirmed by overexpression and GA measurements (Figure 6F, Figure S17A). qPCR, ChIP‐qPCR, EMSA, and Dual‐LUC assays confirmed that NaERFIDOG directly binds to the promoter region of NaKAO1‐like, a key GA biosynthetic enzyme, repressing its expression (Figure 6C–I, Figure S18). We have shown that NaERFIDOG regulates JA and scopoletin biosynthesis by binding to the GCC‐box in the promoter regions of NaAOS, NaOPR2, and NaJAR1 and activating their transcription activity (Figure 5, Figure S13). It would be interesting to investigate whether NaERFIDOG can suppress GA biosynthesis in JA‐deficient irAOC and JA‐insensitive irCOI1 plants to rule out the interference of JA and scopoletin. Our results showed that transient overexpression of NaERF IDOG ‐GFP significantly reduced GA4 levels in both irAOC and irCOI1 plants (Figure S19). This indicated that NaERFIDOG suppresses GA biosynthesis independently of JA and scopoletin. Interestingly, NaERFIDOG also inhibits the basal level of GA. The basal expression levels of NaKAO1‐like, NaGA20ox1‐like, and NaGA3ox1‐like were increased in both NaERF IDOG ‐RNAi and knockout lines (Figure 6C, Figures S11 and S16). However, the expression of the GA degradation enzyme gene NaGA2ox8‐like and the negative regulator candidate gene NaGAI‐like was significantly lower (Figure S16). Accordingly, the basal level of the bioactive gibberellin GA4 was significantly elevated in the NaERF IDOG ‐RNAi line (Figure 6E). Similarly, Ma et al. (2020) reported in rice that the ERF transcription factor OsRPH1 (also known as OsERF061) regulates GA levels by modulating the expression of genes involved in the GA metabolic pathway, thereby affecting plant growth. Thus, our data support that NaERFIDOG suppresses GA biosynthesis through NaKAO1‐like and other GA‐related genes, thereby inhibiting plant growth in N. attenuata . Materials and Methods Plant and Fungal Materials Seeds of the 35th generation of an N. attenuata inbred line were used as the WT genotype. The seeds of N. attenuata transgenic lines, including irAOC (deficient in JA biosynthesis) and irCOI1 (JA‐insensitive) plants were provided by Prof. Ian T. Baldwin (Max‐Planck Institute for Chemical Ecology) (Kallenbach et al. 2012), and Seed germination and plant growth were conducted as described in Krügel et al. (2002). The NaF6'H1‐silenced lines (NaF6'H1‐RNAi‐3# and ‐6#) and NaMYC2a/b‐co‐silenced lines (NaMYC2a/b‐RNAi‐1# and NaMYC2a/b‐RNAi‐2#) were described in Song and Wu (2024b) and Zhao et al. (2025). A. alternata was grown and inoculated on leaves as described in Sun et al. (2014). RNA Extract and Quantitative PCR (qPCR) Total RNA was isolated from plant leaves using TRIzol reagent as described in Wu et al. (2013), and complementary DNA (cDNA) synthesis was performed using the Hifair III 1st Strand cDNA Synthesis SuperMix for qPCR (gDNA digester plus) from Yeasen Biotech according to the manufacturer's instructions (https://www.yeasen.com/). Quantitative PCR (qPCR) was performed on the CFX Connect qPCR instrument (Bio‐Rad) using iTaq Universal SYBR Green Supermix (Bio‐Rad) with specific primers (Table S1) according to the manufacturer's instructions, as described by Song et al. (2019). The Ct values of Actin, Elongation factor 1‐alpha, and 60S ribosomal protein were at the same level in different treatments (Song and Wu 2024a). We selected one of them, Actin, as the reference gene in this study. Transcriptome Sequencing and Analysis WT and NaERF IDOG ‐RNAi‐3# line plants at 40‐day‐old were selected, their source‐sink transition leaves (0 leaves) were inoculated with Alternaria alternata , and leaf samples were collected 2 days later. Total RNA from three biological replicates of leaves was isolated using Trizol reagent. RNA sequencing was conducted by Shanghai OE‐Biotech (http://www.oebiotech.com/) with the Illumina Hiseq 2500. Sequencing was performed at a 10 G of depth, and mapped to the N. attenuata reference genome sequence. The relative abundance of the transcripts was measured as transcript abundance in reads per kilobase of exon model per million mapped reads (RPKM). The raw sequence data reported in this study have been deposited in the Genome Sequence Archive at the BIG Data Center, Beijing Institute of Genomics (BIG), Chinese Academy of Sciences, under accession number (PRJCA045180). Virus‐Induced Gene Silencing (VIGS) VIGS experiments were performed as previously described in Wu et al. (2008). The highly specific fragments of the genes NaERF1‐like, NabHLH18, NaERF IDOG , NabHLH18‐like, and NaERF017 were amplified with specific primer pairs (Table S1). The PCR fragments were digested with HindIII and BamHI and cloned into the pTV00 vector. Agrobacterium tumefaciens (strain GV3101) carrying each of these constructs was mixed with that containing pBINTRA and inoculated into N. attenuata leaves, generating target gene‐silenced plants. Silencing of the phytoene desaturase (PDS) was served as a control to monitor the progress of VIGS (Saedler and Baldwin 2004). When approximately all leaves of PDS‐silenced plants began to bleach, young leaves of VIGS plants at the same leaf position were selected for further experiments. The plants inoculated with the empty vector were used as EV controls. Generation of RNAi and Overexpressing Plants The highly specific sequence of NaERF IDOG was amplified using the primers (Table S1) and inserted into the pRESC8 vector for RNA interference (RNAi). The full coding sequence of NaERF IDOG and NaKAO1‐like was amplified using primers (Table S1) and inserted into the pCAMBIA1301 vector for overexpression. The recombinant vector was introduced into N. attenuata plants by transformation with Agrobacterium tumefaciens LBA4404 as described by Zhao et al. (2021). The single‐insertion RNAi and overexpression lines identified were bred to homozygosity in the T2 generation and used in this study. Generation of NaERF IDOG and NaMYC2a/b Mutants by CRISPR/Cas9 NaERF IDOG and NaMYC2a/b mutants were generated by the CRISPR/Cas9 system as described by Liang and Wu (2022). In brief, two 19 bp DNA fragments, which specifically target two sites of NaERF IDOG , NaMYC2a, or NaMYC2b, were introduced into the pHSE401 vector. These plasmids were then transformed into N. attenuata plants by Agrobacterium tumefaciens LBA4404 as described by Zhao et al. (2021). Primers used for plasmid construction are listed in Table S1. Genomic DNA was extracted from leaves of T0 or T1 plants for PCR. The mutation sites were confirmed by sequencing the PCR products, which were amplified by using specific primers (Table S1). Homozygous gene‐edited NaMYC2a and NaMYC2b were crossed, and the hybrid lines were self‐pollinated for two generations. Lines that were confirmed to carry homozygous mutations at the intended sites were selected and used for this study. Subcellular Localization The coding sequence of NaERFIDOG was cloned into the pCAMBIA3301 vector (Table S1). N. attenuata protoplasts were prepared as described in Song et al. (2019). After incubation for 16–18 h, the signal of 35S::NaERFIDOG‐eGPF was observed using a fluorescence microscope (Leica DM5500 B). The empty vector pCAMBIA3301 was used as a negative control. Sequence Alignment Analysis NaERFIDOG ( N. attenuata , XP_019256547.1), NtERFC3‐like ( Nicotiana tabacum , XP_016505072.1), StERF1B‐like ( Solanum tuberosum , XP_006354500.1), AtERF1 ( Arabidopsis thaliana , NP_188965.1), SlERF1 ( Solanum lycopersicum , AAK95688.1), NtERF5 ( N. tabacum , AAU81956.1), and OsERF061 ( Oryza sativa Japonica Group, XP_015638431.1) were used for sequence alignment, and a phylogenetic tree was constructed. Multiple protein alignment was performed by DNAMAN; The phylogenetic tree was constructed using MEGA7; Protein conserved domain was predicted by NCBI Conserved Domain (www.ncbi.nlm.nih.gov); Protein identity analysis through VectorBuilder (https://en.vectorbuilder.com). Chromatin Immunoprecipitation Coupled With Quantitative PCR Assays (ChIP‐qPCR) ChIP‐qPCR assays were performed using plants that were transiently overexpressing 35S::NaMYC2a/b‐HA or a stable NaERF IDOG ‐HA‐overexpression line. Both of which were inoculated with A. alternata for 2 days. Briefly, 4 g leaves inoculated with A. alternata were harvested at 2 dpi. Leaf samples were subjected to vacuum infiltration with 1% formaldehyde for 15 min to facilitate cross‐linking of protein‐DNA complexes. The reaction was quenched by adding 0.125 M glycine (final concentration) for 10 min. Samples were washed five times with de‐ionized water and ground to a fine powder in liquid nitrogen. Chromatin was sheared into fragments of 200–500 bp using a Bioruptor pico (diagenode) with 7 cycles of 30s ON/30 s OFF in a water bath maintained at 4°C. The protein‐DNA complex was incubated at 4°C with anti‐HA antibody (CST#3724, 1:50 dilution) overnight. Rabbit IgG (CST#2729, 1:50 dilution) was used as a negative control. The antibody‐protein‐DNA immune complex was captured with Protein A/G Magnetic beads (Vazyme Biotech) for 4 h at 4°C. The precipitated DNA was analysed by qPCR. The enrichment of each fragment was calculated by normalizing the amount of a target DNA fragment against a genomic fragment of Actin as an internal control. All the primers are listed in Table S1. Electrophoretic Mobility Shift Assays (EMSA) The coding sequences of NaERF IDOG , NaMYC2a, and NaMYC2b were amplified with specific primers (Table S1) and fused into the glutathione S‐transferase (GST)‐fusing pGEX‐4T‐1 vector to generate the NaERFIDOG‐GST, NaMYC2a‐GST and NaMYC2b‐GST. The combined protein was induced with 0.2–0.4 mM isopropyl‐beta‐D‐thiogalactopyranoside (IPTG) in Escherichia coli BL21 and purified using GST‐tag purification agarose (Beyotime). The G‐box (MYC) and GCC‐box (ERF) motif sequences were retrieved from JASPAR (https://jaspar.elixir.no/). The putative binding G‐box and GCC‐box motifs of the promoters of the target genes were predicted by MEME (https://meme‐suite.org/meme/doc/meme.html), and oligonucleotide probes were labelled with biotin at the 5′ end. The fusion protein was incubated with labelled biotin probe for specific binding detection using an EMSA kit (Beyotime) according to the manufacturer's instructions. The unlabeled biotin probes were used as a cold competitor, and the labelled probes incubated with GST protein were used as negative controls. Dual Luciferase Transcriptional Activity Assay (Dual‐LUC) The promoters of NaERF IDOG , NaF6'H1, NaAOS, NaOPR2, NaJAR1 and NaKAO1‐like were amplified with specific primers and cloned into the pCAMBIA3301‐LUC‐REN reporter vector. The coding sequences of NaMYC2a, NaMYC2b and NaERF IDOG were amplified with specific primers and inserted into the pCAMBIA3301 effector vector. The constructed reporter and effector vectors were transformed into Agrobacterium tumefaciens GV3101 strain and transiently expressed in N. attenuata leaves for 48 h. Luciferase (LUC) and Renilla luciferase (REN) activities were measured using a dual luciferase assay kit (Yeasen Biotech). The LUC/REN ratio was used to determine the transcriptional activity of the promoter. Table S1 lists the primers used. Quantification of Scopoletin, JA and GA The quantification and determination of scopoletin and JA were previously described in Sun et al. (2014) and Wu et al. (2008). Samples were ground in liquid nitrogen using a mixer mill to a fine powder. Scopletin were extracted with 70% methanol (v/v), and JA were by ethyl acetate containing the internal standard (20 ng D6‐JA or 5 ng D6‐JA‐Ile) and 70% methanol (v/v). Then the samples were subjected to HPLC‐MS/MS. For GA analysis, 0.15 g leaves were ground into a fine powder. Add 500 μL extraction buffer (75% methanol, 20% H2O, and 5% formic acid) containing the 1 μL internal standard (5 ng/μL D2‐GA1 and 5 ng/μL D2‐GA4). Extracts were analysed by HPLC‐MS/MS as described previously (Liu et al. 2019). GA3 and GA4 were quantified using the internal standard D2‐GA4, and GA1 with D2‐GA1. Exogenous Phytohormones MeJA, GA, and Phytoalexin Scopoletin Treatment Solutions of 10 μM MeJA, 100 μM GA3, 50 μM PAC (paclobutrazol), and 100 μM scopoletin were prepared, with water as the control. These solutions were applied twice daily via foliar spray to rosette‐stage plants (30‐day‐old) leaves. After 20 days of treatment, rosette diameters were measured and recorded. Accession Numbers The GenBank accession numbers of the genes in this study are as follows: NaERF IDOG (XM_019401002.1), NaMYC2a (XM_019398607.1), NaMYC2b (XM_019368208.1), NaF6'H1 (XM_019402034.1), NaAOS (XM_019399851.1), NaOPR2 (XM_019387447.1), NaJAR1 (XM_019374933.1), NaJAZa (XM_019385384.1), NaJAZc (XM_019398932.1), NaJAZf (XM_019369600.1), NaJAZh (XM_019379894.1), NaJAZj (XM_019368408.1), NaKAO1‐like (XM_019397098.1), NaGA20ox1‐like (XM_019403999.1), NaGA3ox1‐like (XM_019393510.1), NaGA2ox2‐like (XM_019398503.1), NaGA2ox8‐like (XM_019395303.1), NaGAI‐like (XM_019385968.1), NaERF1‐like (XM_019377263.1), NabHLH18 (XM_019411940.1), NabHLH18‐like (XM_019373105.1), and NaERF017 (XM_019378163.1). Author Contributions Jinsong Wu, Lei Wang, and Luyang Zhao conceived the project, designed the experiments, and drafted the manuscript. Na Song screened all the transcription factors induced by A. alternata in WT but not in irAOC plants, performed the VIGS experiment and found NaERFIDOG. Luyang Zhao performed all the rest experiments and analysed the data. Funding This project was supported by the National Natural Science Foundation of China (NSFC grant No. 32370311) to Prof. Jinsong Wu and the Yunnan Innovation Team Project (202505AS350018) to Prof. Lei Wang. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Figure S1: The top five transcription factors highly induced by A. alternata in WT plants but not in JA‐deficient irAOC plants. Figure S2: Silencing NaERF1‐like, NabHLH18, NabHLH18‐like, or NaERF017 individually with VIGS. Figure S3: Sequence alignment of NaERFIDOG with its homologues. Figure S4: Self‐activation of NaERFIDOG transcription. Figure S5: NaERFIDOG confers the resistance of N. attenuata to A. alternata . Figure S6: NaERF IDOG knockout mutants generated by CRISPR/Cas9 showed reduced resistance to A. alternata . Figure S7: NaMYC2a/b confers the resistance of N. attenuata to A. alternata , and overexpression of NaERF IDOG enhances the resistance of NaMYC2a/b‐RNAi plants. Figure S8: NaMYC2a/b double knockout mutants generated by CRISPR/Cas9 showed reduced basal and A. alternata ‐induced NaERF IDOG expression and A. alternata resistance. Figure S9: JA‐induced inhibition of N. attenuata growth. Figure S10: NaERF IDOG and NaMYC2a/b knockout mutants grow bigger. Figure S11: Expression of NaF6'H1, NaAOS, NaOPR2, NaJAR1, and NaKAO1‐like in NaERF IDOG knockout mutants at 2 dpi. Figure S12: Scopoletin production inhibits the growth of N. attenuata . Figure S13: NaERFIDOG directly regulates the expression of NaOPR2 and NaJAR1. Figure S14: NaERFIDOG negatively regulates NaJAZs expression. Figure S15: A. alternata inoculation inhibits GA production, and GA negatively regulates the resistance of N. attenuata to A. alternata . Figure S16: NaERFIDOG regulates the expression of GA‐related genes. Figure S17: Overexpression of NaKAO1‐like enhances GA4 production and plant growth, leads to N. attenuata plants more susceptible to A. alternata . Figure S18: The Dual‐LUC assays indicated NaERF IDOG overexpression suppresses the transcription activity of the NaKAO1‐like promoter. Figure S19: NaERFIDOG represses GA4 biosynthesis in WT, irAOC and irCOI1 plants. Figure S20: The binding of MYC2a/b to the NaERF IDOG promoter is enhanced after A. alternata infection. Figure S21: NaMYC2a/b‐regulated NaF6'H1 and NaKAO1‐like expression and disease resistance was blocked in the NaERF IDOG knockout mutant. Table S1: Primer sequences used in this study.